The Centre for Biologic Therapies (CBT) focuses on advancing early-phase biologics discovery and developing antibody-based therapeutics to treat human diseases. Our mission is to accelerate the delivery of high-quality, clinic-ready therapies that bring medicines, vaccines, and treatments to patients sooner. By leveraging state-of-the-art antibody discovery platforms, advanced engineering, and lead optimisation technologies, we aim to transform research into life-changing treatments.
Our multidisciplinary team of scientists drives innovation through collaboration with researchers, clinician-scientists, and industry experts, fostering translational pathways and creating a dynamic environment for scientific exploration.
